TUESDAY, Oct. 31, 2023 (HealthDay News) — The Biden administration is encouraging schools throughout the United States to carry naloxone to help prevent fatal drug overdoses in students. The medication (Narcan) was approved earlier this year as an over-the-counter (OTC) nasal spray.  Faculty and students should be prepared to useContinue Reading

MONDAY, Oct. 30, 2023 (HealthDay News) — Federal regulators are warning consumers to stop using eyedrops and gels from several major brands after finding unsanitary conditions in a manufacturing plant. Twenty-six eye care products are part of the alert. Contaminated products have the potential to cause eye infection and blindnessContinue Reading

MONDAY, Oct. 30, 2023 (HealthDay News) — Patients with sickle cell disease may soon have two new treatments to try. On Tuesday, a U.S. Food and Drug Administration advisory committee will weigh the merits of a new gene therapy for the painful, inherited condition, which typically strikes Black people. The agencyContinue Reading

TUESDAY, Oct. 24, 2023 (HealthDay News) — Demand for a new shot that protects babies against respiratory syncytial virus (RSV) has outpaced supply, prompting U.S. health officials to recommend the doses be saved for high-risk infants. In an alert posted Monday afternoon, the U.S. Centers for Disease Control and PreventionContinue Reading